Skip to main content
. 2020 Mar 26;30(1):27–37. doi: 10.1136/bmjqs-2019-009821

Table 2.

Secondary patient outcomes

Before After Effect estimate
(95% CI)*
Time point 1: discharge or ward transfer
HCAHPS35
 Nursing services† n, mean (SD) 95, 0.63 (0.42) 122, 0.66 (0.37) 0.07 (−0.08 to 0.23)
 Doctor communication n, mean (SD) 302, 0.77 (0.38) 367, 0.77 (0.38) 0.09 (0.00 to 0.19)
 Physical environment n, mean (SD) 276, 0.49 (0.31) 347, 0.49 (0.31) 0.06 (−0.03 to 0.16)
 Pain control*† n, mean (SD) 232, 0.69 (0.40) 244, 0.69 (0.40) 0.13 (0.00 to 0.26)
 Communication about medicines† n, mean (SD) 191, 0.54 (0.40) 215, 0.54 (0.40) 0.07 (−0.06 to 0.21)
 Discharge information n, mean (SD) 233, 0.65 (0.48) 249, 0.65 (0.48) 0.09 (−0.06 to 0.24)
 Fatigue and nausea† n, mean (SD) 91, 0.79 (0.35) 88, 0.79 (0.35) −0.12 (−0.31 to 0.06)
 Overall health n, mean (SD) 280, 0.45 (0.26) 345, 0.45 (0.26) −0.02 (−0.09 to 0.05)
PANAS48
 Positive Affect Scale n, mean (SD) 244, 26.7 (8.2) 263, 26.7 (8.2) −0.18 (−2.86 to 2.51)
 Negative Affect Scale n, mean (SD) 251, 16.9 (6.6) 279, 16.9 (6.6) −2.01 (−3.84 to −0.18)
HADS43
 Anxiety n, mean (SD) 258, 5.8 (4.2) 314, 5.8 (4.2) −0.63 (−1.77 to 0.51)
 Depression n, mean (SD) 259, 5.0 (3.9) 321, 5.0 (3.9) −0.49 (−1.54 to 0.55)
EORTC42
 Pain n, mean (SD) 281, 46.6 (33.1) 323, 46.6 (33.1) −7.6 (−17.5 to 2.3)
 Fatigue n, mean (SD) 282, 59.2 (26.4) 324, 59.2 (26.4) −5.6 (−13.4 to 2.2)
 Nausea/vomiting n, mean (SD) 279, 15.9 (24.1) 321, 15.9 (24.1) −1.4 (−6.0 to 8.7)
Ward rating
 Confidence in future treatment n, mean (SD) 292, 8.49 (1.9) 357, 8.9 (1.6) 0.32 (−0.12 to 0.80)
 Overall ward rating n, mean (SD) 293, 8.5 (1.6) 359, 8.9 (1.5) 0.46 (0.01 to 0.92)
HCAHPS recommendation to family/friends35
 Definitely yes n/N (%) 181/294 (61.6) 255/360 (70.8) 0.71 (0.40 to 1.26)
 Probably yes n/N (%) 91/294 (31.0) 87/360 (24.2)
 Probably no n/N (%) 16/294 (5.4) 10/360 (2.8)
 Defiantly no n/N (%) 6/294 (2.0) 8/360 (2.2)
Time point 2: 4–6 weeks after discharge/ward transfer
HCAHPS35
 Overall health n, mean (SD) 130, 0.43 (0.28) 149, 0.40 (0.24) −0.05 (−0.14 to 0.05)
EORTC42
 Pain n, mean (SD) 128, 34.9 (30.0) 150, 37.1 (34.9) −0.5 (−12.6 to 11.7)
 Fatigue n, mean (SD) 129, 45.6 (29.5) 147, 50.3 (29.7) 5.9 (−5.4 to 17.3)
 Nausea/vomiting n, mean (SD) 127, 8.3 (16.5) 149, 9.7 (20.0) −0.7 (−8.7 to 7.2)
 HCAHPS recommendation to family/friends35
 Definitely yes n/N (%) 76/131 (58.0) 96/150 (64.0) 0.79 (0.31 to 2.09)
 Probably yes n/N (%) 40/131 (30.5) 46/150 (30.5)
 Probably no n/N (%) 12/131 (9.2) 6/150 (9.2)
 Definitely no n/N (%) 3/131 (2.3) 2/150 (2.3)
Patient Enablement Instrument score44 n, mean (SD) 99, 4.05 (3.86) 107, 4.31 (3.75) 0.03 (−1.63 to 1.68)
Ward rating
 Overall ward rating n, mean (SD) 132, 8.1 (1.6) 153, 8.6 (1.5) 0.68 (0.49 to 1.31)
 Confidence in future treatment n, mean (SD) 131, 8.4 (1.9) 151, 8.9 (1.7) 0.72 (−0.02 to 1.47)

Results in bold indicate statistically significant improvements.

*Effect estimate is the adjusted mean difference, except for recommendation to family/friends where it is an odds ratio.

†There were screening questions for nursing services, pain control, communication about medicines and fatigue/nausea, so these scrores were only calculated for applicable patients

EORTC, European Organization for the Research and Treatment of Cancer; HADS, Hospital Anxiety and Depression Scale; HCAHPS, Hospital Consumer Assessment of Healthcare Providers and Systems; PANAS, Positive and Negative Affect Schedule.